SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950142-02-000237
Filing Date
2002-03-06
Accepted
2002-03-06 00:00:00
Documents
3
Group Members
GEORGE SOROSPERSEUS CAPITAL, LLCPERSEUS MANAGEMENT, LLCPERSEUS, LLCPSV GP, LLCPSV PARTNERS, LLCPSV, LPRAPPAHANNOCK INVESTMENT COMPANYSFM AH, INC.SFM PARTICIPATION, L.P.SOROS FUND MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 sc13da6-viropharma.txt SC 13D/A 44798
3 EXHIBIT 2 ex2sc13da6-viropharma.txt EX-99 96476
4 EXHIBIT 3 ex3sc13da6-viropharma.txt EX-99 64746
  Complete submission text file 0000950142-02-000237.txt   208620
Mailing Address 888 SEVENTH AVE 33RD FLR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 212-262--6
SOROS GEORGE (Filed by) CIK: 0000900203 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
SIC: 0000

Mailing Address 76 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 405 EAGLEVIEW BLVD PO BOX 5000 EXTON PA 19341 6104587300
VIROPHARMA INC (Subject) CIK: 0000946840 (see all company filings)

IRS No.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48239 | Film No.: 02568512
SIC: 2834 Pharmaceutical Preparations